Peter Jirak

Minnesota State University Moorhead — United States

Medicine · Health Sciences

19h-index1.4kcitations73works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

GDF15 and Related Biomarkers(13), Heart Failure Treatment and Management(10), COVID-19 Clinical Research Studies(8), Acute Myocardial Infarction Research(7), Cardiovascular Function and Risk Factors(7)

Publications71 total

Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study
Journal of Clinical Medicine·2025· 4 citedOpen Access
Parabolic flight as a space-flight analogon impacts angiogenesis and lipid metabolism
Life Sciences in Space Research·2025Open Access
Impact of Atrial Lead Position on Functional Cardiac Parameters in Patients Requiring Dual-Chamber Pacemaker Implantation
Journal of Clinical Medicine·2025Open Access
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
Frontiers in Pharmacology·2023· 5 citedOpen Access
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
Frontiers in Pharmacology·2023· 3 citedOpen Access
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
Journal of Clinical Medicine·2023· 5 citedOpen Access
Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
Frontiers in Cardiovascular Medicine·2023· 3 citedOpen Access
SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
Journal of the American College of Cardiology·2023Open Access
Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessness
Clinical Hemorheology and Microcirculation·2023· 4 cited
Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
Biomedicines·2022· 12 citedOpen Access
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
European Heart Journal Acute Cardiovascular Care·2022· 19 citedOpen Access
Prognostic impact of cavotricuspid isthmus ablation for typical atrial flutter in patients with heart failure and reduced ejection fraction
European Heart Journal·2022Open Access
Effects of angiotensin receptor-neprilysin inhibitors (ARNIs) on the glucose and fat metabolism biomarkers leptin and fructosamin
European Heart Journal·2022Open Access
Impact of socioeconomic aspects on cardiac implantable electronic device treatment and application of the EHRA guidelines
Wiener klinische Wochenschrift·2022· 4 cited
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
Frontiers in Cardiovascular Medicine·2022· 15 citedOpen Access
Main pulmonary artery diameter in combination with cardiovascular biomarkers: new possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis
Minerva Medica·2022· 7 cited
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
Frontiers in Medicine·2022· 20 citedOpen Access
Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
Life·2022· 1 citedOpen Access
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
Journal of Personalized Medicine·2022· 6 citedOpen Access
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
The Lancet·2022· 296 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Uta C. Hoppe(39), Lukas J. Motloch(24), Bernhard Wernly(23), Vera Paar(21), Michael Lichtenauer(20), Michael Lichtenauer(19), Christian Jung(18), Moritz Mirna(17), Rudin Pistulli(16), Kristen Kopp(13), Albert Topf(11), Daniel Kretzschmar(9), Н. Ш. Загидуллин(9), Richard Rezar(8), P. Christian Schulze(8), Marcus Franz(8), Alexander Lauten(8), Lukas Fiedler(7), Д. Ф. Гареева(6), И. А. Лакман(6)